lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p.
TLDR
A pivotal role of CYTOR is demonstrated in mediating tamoxifen resistance in breast cancer through regulation of miR-125a-5p, CYTOR elevated serum response factor (SRF) expression and activated Hippo and mitogen associated protein kinase signaling pathways to promote breast cancer cell survival upon tamoxIFen treatment.Abstract:
Development of resistance to endocrine therapy, such as tamoxifen, remains a tricky clinical problem during the treatment of breast cancer. Accumulating evidence suggested that dysregulation of long noncoding (lnc_RNAs contributes to the development of tamoxifen resistance. In the current study, via screening, cytoskeleton regulator RNA (CYTOR) was identified as the most significantly elevated lncRNA in the established tamoxifen resistant MCF7 cell lines (MCF7/TAM1 and MCF7/TAM2) compared with the parental MCF7 cells (MCF7‑P). The CCK‑8 assay indicated that silencing of CYTOR increased the sensitivity of MCF7/TAM1 and MCF7/TAM2 to tamoxifen treatment. Using bioinformatic analysis, it was predicted that microRNA (miR)‑125a‑5p might bind to CYTOR and the expression of miR‑125a‑5p was negatively correlated with CYTOR in the tumor tissues of breast cancer. In addition, RT‑qPCR and dual luciferase assays validated that CYTOR directly repressed miR‑125a‑5p expression in breast cancer cells. Through regulation of miR‑125a‑5p, CYTOR elevated serum response factor (SRF) expression and activated Hippo and mitogen associated protein kinase signaling pathways to promote breast cancer cell survival upon tamoxifen treatment. In the collected tumor tissues of breast cancer in the present study, high expression of CYTOR was detected in tissues from patients with no response to tamoxifen compared with those from patients who were not treated with tamoxifen. A positive correlation between CYTOR and SRF mRNA expression was observed in tissues collected from patients with breast cancer. In conclusion, the results of the present study demonstrated a pivotal role of CYTOR in mediating tamoxifen resistance in breast cancer.read more
Citations
More filters
Journal ArticleDOI
Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
Monica Cantile,Maurizio Di Bonito,Margherita Cerrone,Francesca Collina,Michelino De Laurentiis,Gerardo Botti +5 more
TL;DR: The role of HOTAIR in cancer progression and drug resistance, in particular in BC, is summarized, and the main approaches for silencing it are illustrated.
Journal ArticleDOI
Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma.
Shuwei Chen,Muwen Yang,Chunyang Wang,Ying Ouyang,Xiangfu Chen,Jiewen Bai,Yameng Hu,Ming Song,Siyi Zhang,Siyi Zhang,Quan Zhang +10 more
TL;DR: It is revealed that Forkhead (FOXD1) is upregulated in OSCC and predicted poor prognosis, and the CYTOR/LPP axis was proven to be essential for FOXD1-induced EMT and chemoresistance of OSCC.
Journal ArticleDOI
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
TL;DR: In this article, the authors summarize the current literature describing lncRNA-miRNA interactions that are critical in the molecular mechanisms that regulate EMT, CSCs and drug resistance in breast cancer.
Journal ArticleDOI
The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.
TL;DR: The comprehensive role of Hippo‐related lncRNAs in tumour progression is summarized, their clinical diagnostic, prognostic or therapeutic potentials in tumours are depicted and they are poised to become important putative biomarkers and therapeutic targets in human cancers.
Journal ArticleDOI
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
TL;DR: In this article, the authors systematically elucidate the general characteristics, potential mechanisms, and targeted therapy of long non-coding RNAs and discuss the emerging functions of lncRNAs in breast cancer.
References
More filters
Journal ArticleDOI
Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
Journal ArticleDOI
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,Rebecca L. Siegel,Lindsey A. Torre,Ahmedin Jemal +5 more
TL;DR: A status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.
Journal ArticleDOI
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
TL;DR: It is proposed that this "competing endogenous RNA" (ceRNA) activity forms a large-scale regulatory network across the transcriptome, greatly expanding the functional genetic information in the human genome and playing important roles in pathological conditions, such as cancer.
Journal ArticleDOI
Evolution and functions of long noncoding RNAs
TL;DR: The evolution of long noncoding RNAs and their roles in transcriptional regulation, epigenetic gene regulation, and disease are reviewed.
Journal ArticleDOI
Long Noncoding RNA and Cancer: A New Paradigm.
TL;DR: The emerging functions and association of lncRNAs in different types of cancer and their potential implications in cancer diagnosis and therapy are reviewed.
Related Papers (5)
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
Yashar S. Niknafs,Sumin Han,Teng Ma,Corey Speers,Chao Zhang,Kari Wilder-Romans,Matthew K. Iyer,Sethuramasundaram Pitchiaya,Rohit Malik,Yasuyuki Hosono,John R. Prensner,Anton Poliakov,Udit Singhal,Lanbo Xiao,Steven Kregel,Ronald F. Siebenaler,Shuang G. Zhao,Michael Uhl,Alexander R. Gawronski,Daniel F. Hayes,Lori J. Pierce,Xuhong Cao,Colin Collins,Rolf Backofen,Cenk Sahinalp,Cenk Sahinalp,Cenk Sahinalp,James M. Rae,Arul M. Chinnaiyan,Felix Y. Feng +29 more